Cost-effectiveness of first-line immunotherapy for advanced non-small cell lung cancer with different PD-L1 expression levels: A comprehensive overview
Article in Critical Reviews in Oncology/Hematology (November 2023)
The most recent citing publication is shown below. View this citation on Dimensions.
Article in Critical Reviews in Oncology/Hematology (November 2023)